SCHEMBL3282245

SCHEMBL3282245

COc1ccc(C(=O)O)c(-c2ccc(Cl)cc2)c1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
ALDH1A1 P00352 4/20 0.46
TDP1 Q9NUW8 2/20 0.46
HPGD P15428 2/20 0.46
MAPK1 P28482 1/20 0.46
MRGPRX4 Q96LA9 2/20 0.45
GRIK1 P39086 1/20 0.45
MAPT P10636 3/20 0.45
POLB P06746 2/20 0.45
MEN1 O00255 1/20 0.45
LMNA P02545 1/20 0.45
KMT2A Q03164 1/20 0.45
AKR1C3 P42330 1/20 0.45
AKR1C2 P52895 1/20 0.45
KDM4E B2RXH2 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6524603 0.82 XDH (0.47) ALDH1A1TDP1HPGDMAPTPOLB
SCHEMBL6718909 0.80 FABP4 (0.56) CA12CA1CA2CA7CA9
SCHEMBL28750800 0.80 NPC1 (0.46) HPGDPOLBLMNAKDM4EFABP4
SCHEMBL1921213 0.80 ALDH1A1 (0.56) ALDH1A1HPGDGRIK1AKR1C3AKR1C2
SCHEMBL927573 0.75 ALDH1A1 (0.62) CA1CA2ALDH1A1TDP1HPGD
SCHEMBL48961 0.75 MRGPRX4 (0.64) CA1CA2ALDH1A1TDP1HPGD
SCHEMBL30100412 0.75 MRGPRX4 (0.64) CA1CA2ALDH1A1TDP1HPGD
SCHEMBL2405475 0.75 ALDH1A1 (0.55) ALDH1A1TDP1HPGDMAPK1MRGPRX4
SCHEMBL10418678 0.74 CA1 (0.47) CA12CA1CA2CA9ALDH1A1
SCHEMBL25285914 0.74 CA12 (0.61) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7705053-B2 Benzamide derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2010-04-27 US disclosed
US-20070123493-A1 Benzamide derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2007-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070123493-A1 Benzamide derivative BDKRB1, BDKRB2, NR1H2 CA12 2136/4885CA1 2122/4885CA2 715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.